Cargando…
Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
Human immunodeficiency virus type 1 (HIV-1) integrase inhibitors belong to a novel class of antiretroviral drugs with high potency and better tolerability. Elvitegravir (EVG) is the second integrase inhibitor approved by the US Food and Drug Administration when administered in combination with a nov...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037326/ https://www.ncbi.nlm.nih.gov/pubmed/24876793 http://dx.doi.org/10.2147/HIV.S39178 |